Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 39

1.

Ail proteins of Yersinia pestis and Y. pseudotuberculosis have different cell binding and invasion activities.

Tsang TM, Wiese JS, Felek S, Kronshage M, Krukonis ES.

PLoS One. 2013 Dec 27;8(12):e83621. doi: 10.1371/journal.pone.0083621. eCollection 2013.

2.

A combined metabonomic and proteomic approach identifies frontal cortex changes in a chronic phencyclidine rat model in relation to human schizophrenia brain pathology.

Wesseling H, Chan MK, Tsang TM, Ernst A, Peters F, Guest PC, Holmes E, Bahn S.

Neuropsychopharmacology. 2013 Nov;38(12):2532-44. doi: 10.1038/npp.2013.160. Epub 2013 Jul 3.

3.

Macrophage M1/M2 polarization dynamically adapts to changes in cytokine microenvironments in Cryptococcus neoformans infection.

Davis MJ, Tsang TM, Qiu Y, Dayrit JK, Freij JB, Huffnagle GB, Olszewski MA.

MBio. 2013 Jun 18;4(3):e00264-13. doi: 10.1128/mBio.00264-13.

4.

Molecular validation of the acute phencyclidine rat model for schizophrenia: identification of translational changes in energy metabolism and neurotransmission.

Ernst A, Ma D, Garcia-Perez I, Tsang TM, Kluge W, Schwarz E, Guest PC, Holmes E, Sarnyai Z, Bahn S.

J Proteome Res. 2012 Jul 6;11(7):3704-14. doi: 10.1021/pr300197d. Epub 2012 Jun 1.

PMID:
22613019
5.

Ail protein binds ninth type III fibronectin repeat (9FNIII) within central 120-kDa region of fibronectin to facilitate cell binding by Yersinia pestis.

Tsang TM, Annis DS, Kronshage M, Fenno JT, Usselman LD, Mosher DF, Krukonis ES.

J Biol Chem. 2012 May 11;287(20):16759-67. doi: 10.1074/jbc.M112.358978. Epub 2012 Mar 23.

6.

Structural insights into Ail-mediated adhesion in Yersinia pestis.

Yamashita S, Lukacik P, Barnard TJ, Noinaj N, Felek S, Tsang TM, Krukonis ES, Hinnebusch BJ, Buchanan SK.

Structure. 2011 Nov 9;19(11):1672-82. doi: 10.1016/j.str.2011.08.010.

7.

The methylazoxymethanol acetate (MAM-E17) rat model: molecular and functional effects in the hippocampus.

Hradetzky E, Sanderson TM, Tsang TM, Sherwood JL, Fitzjohn SM, Lakics V, Malik N, Schoeffmann S, O'Neill MJ, Cheng TM, Harris LW, Rahmoune H, Guest PC, Sher E, Collingridge GL, Holmes E, Tricklebank MD, Bahn S.

Neuropsychopharmacology. 2012 Jan;37(2):364-77. doi: 10.1038/npp.2011.219. Epub 2011 Sep 28.

8.

Effect of cytokine interplay on macrophage polarization during chronic pulmonary infection with Cryptococcus neoformans.

Arora S, Olszewski MA, Tsang TM, McDonald RA, Toews GB, Huffnagle GB.

Infect Immun. 2011 May;79(5):1915-26. doi: 10.1128/IAI.01270-10. Epub 2011 Mar 7.

9.

Evidence for disease and antipsychotic medication effects in post-mortem brain from schizophrenia patients.

Chan MK, Tsang TM, Harris LW, Guest PC, Holmes E, Bahn S.

Mol Psychiatry. 2011 Dec;16(12):1189-202. doi: 10.1038/mp.2010.100. Epub 2010 Oct 5.

PMID:
20921955
10.

Three Yersinia pestis adhesins facilitate Yop delivery to eukaryotic cells and contribute to plague virulence.

Felek S, Tsang TM, Krukonis ES.

Infect Immun. 2010 Oct;78(10):4134-50. doi: 10.1128/IAI.00167-10. Epub 2010 Aug 2.

11.

Ail binding to fibronectin facilitates Yersinia pestis binding to host cells and Yop delivery.

Tsang TM, Felek S, Krukonis ES.

Infect Immun. 2010 Aug;78(8):3358-68. doi: 10.1128/IAI.00238-10. Epub 2010 May 24.

12.

Phosphoglucomutase of Yersinia pestis is required for autoaggregation and polymyxin B resistance.

Felek S, Muszyński A, Carlson RW, Tsang TM, Hinnebusch BJ, Krukonis ES.

Infect Immun. 2010 Mar;78(3):1163-75. doi: 10.1128/IAI.00997-09. Epub 2009 Dec 22.

13.

Analyzing the effects of psychotropic drugs on metabolite profiles in rat brain using 1H NMR spectroscopy.

McLoughlin GA, Ma D, Tsang TM, Jones DN, Cilia J, Hill MD, Robbins MJ, Benzel IM, Maycox PR, Holmes E, Bahn S.

J Proteome Res. 2009 Apr;8(4):1943-52.

PMID:
19714815
14.

Metabonomic characterization of the 3-nitropropionic acid rat model of Huntington's disease.

Tsang TM, Haselden JN, Holmes E.

Neurochem Res. 2009 Jul;34(7):1261-71. doi: 10.1007/s11064-008-9904-5. Epub 2009 Jan 16.

PMID:
19148750
15.

Systemic multicompartmental effects of the gut microbiome on mouse metabolic phenotypes.

Claus SP, Tsang TM, Wang Y, Cloarec O, Skordi E, Martin FP, Rezzi S, Ross A, Kochhar S, Holmes E, Nicholson JK.

Mol Syst Biol. 2008;4:219. doi: 10.1038/msb.2008.56. Epub 2008 Oct 14.

16.

Metabolic changes in schizophrenia and human brain evolution.

Khaitovich P, Lockstone HE, Wayland MT, Tsang TM, Jayatilaka SD, Guo AJ, Zhou J, Somel M, Harris LW, Holmes E, Pääbo S, Bahn S.

Genome Biol. 2008;9(8):R124. doi: 10.1186/gb-2008-9-8-r124. Epub 2008 Aug 5.

17.

Pyruvate dehydrogenase complex activity controls metabolic and malignant phenotype in cancer cells.

McFate T, Mohyeldin A, Lu H, Thakar J, Henriques J, Halim ND, Wu H, Schell MJ, Tsang TM, Teahan O, Zhou S, Califano JA, Jeoung NH, Harris RA, Verma A.

J Biol Chem. 2008 Aug 15;283(33):22700-8. doi: 10.1074/jbc.M801765200. Epub 2008 Jun 9.

18.

Metabonomic analysis identifies molecular changes associated with the pathophysiology and drug treatment of bipolar disorder.

Lan MJ, McLoughlin GA, Griffin JL, Tsang TM, Huang JT, Yuan P, Manji H, Holmes E, Bahn S.

Mol Psychiatry. 2009 Mar;14(3):269-79. doi: 10.1038/sj.mp.4002130. Epub 2008 Feb 5.

PMID:
18256615
19.

CSF metabolic and proteomic profiles in patients prodromal for psychosis.

Huang JT, Leweke FM, Tsang TM, Koethe D, Kranaster L, Gerth CW, Gross S, Schreiber D, Ruhrmann S, Schultze-Lutter F, Klosterkötter J, Holmes E, Bahn S.

PLoS One. 2007 Aug 22;2(8):e756.

20.

Metabolic profiling of CSF: evidence that early intervention may impact on disease progression and outcome in schizophrenia.

Holmes E, Tsang TM, Huang JT, Leweke FM, Koethe D, Gerth CW, Nolden BM, Gross S, Schreiber D, Nicholson JK, Bahn S.

PLoS Med. 2006 Aug;3(8):e327.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk